Cho N, Shaw J, Karuranga S, Huang Y, da Rocha FJ, Ohlrogge A, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.
Dros J, Wewerinke A, Bindels PJ, van Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009;7(6):555–8.
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population based cohort. Neurology. 1993;43(4):817.
Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of incident diabetic neuropathy using the monofilament examination. Diabetes Care. 2010;33(7):1549–54.
Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract. 2008;8(1):45–56.
Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158(2):157–62.
Caselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002;25(6):1066–71.
Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158(3):289–92.
Turner R, Holman R, Stratton I, Cull C, Matthews D, Manley S, et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131).
Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.
Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg. 1998;37(6):460–6.
Plank J, Haas W, Rakovac I, Görzer E, Sommer R, Siebenhofer A, et al. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care. 2003;26(6):1691–5.
Schaper N, van Netten J, Apelqvist J, Bus S, Hintchliffe R, Lipsky B. IWGDF Practical guidelines on the prevention and management of diabetic foot disease. wwwiwgdfguidelinesorg. 2019.
American Diabetes Association. Microvascular complications and foot care: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S105.
Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(11):S17.
Mueller MJ, Hastings M, Commean PK, Smith KE, Pilgram TK, Robertson D, et al. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36(7):1009–17.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. J Am Med Assoc. 2005;293(2):217–28.
Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17(6):557–60.
Woodbury MG, Sibbald RG, Ostrow B, Persaud R, Lowe JM. Tool for rapid & easy identification of high risk diabetic foot: validation & clinical pilot of the simplified 60 second diabetic foot screening tool. PLoS One. 2015;10(6):e0125578.
Young D, Schuerman S, Flynn K, Hartig K, Moss D, Altenburger B. Reliability and responsiveness of an 18 site, 10-g monofilament examination for assessment of protective foot sensation. J Geriatr Phys Ther. 2011;34(2):95–8.
Meijer J-WG, Smit AJ, Lefrandt JD, Van Der Hoeven JH, Hoogenberg K, Links TP. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care. 2005;28(9):2201–5.
O'Neill J, McCann S, Lagan K. Tuning fork (128 Hz) versus neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus. Int J Clin Pract. 2006;60(2):174–8.
Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24(2):250–6.
Thivolet C, El Farkh J, Petiot A, Simonet C, Tourniaire J. Measuring vibration sensations with graduated tuning fork: simple and reliable means to detect diabetic patients at risk of neuropathic foot ulceration. Diabetes Care. 1990;13(10):1077–80.
Van Deursen RWM, Sanchez M, Derr J, Becker M, Ulbrecht J, Cavanagh PR. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability. Diabet Med. 2001;18(6):469–75.
Zhang Q, Yi N, Liu S, Zheng H, Qiao X, Xiong Q, et al. Easier operation and similar power of 10 g monofilament test for screening diabetic peripheral neuropathy. J Int Med Res. 2018;46(8):3278–84.
Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment a report of the task force of the foot care interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679–85.
Lee S, Kim H, Choi S, Park Y, Kim Y, Cho B. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci. 2003;18(1):103.
Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care. 2000;23(7):984–8.
Spruce MC. Neurological Assessment. In: Yates B, editor. Merriman's Assessment of the lower limb. 3rd ed. Philadelphia: Churchill Livingstone Elsevier; 2009. p. 146.
Menz HB. Two feet, or one person? Problems associated with statistical analysis of paired data in foot and ankle medicine. Foot (Edinburgh, Scotland). 2004;14(1):2–5.
Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.
Fleiss JL. Measuring nominal scale agreement among many raters. Pyschological Bull. 1971;76(5):378–82.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.
Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85(3):257–68.
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–62.
Davies A. Repeatability of clinical tests for diabetes related peripheral neuropathy. 2016. https://doi.org/10.13140/RG.2.2.25948.39042.
Portney L, Watkins M. Foundations of clinical research: applications to practice. 3rd Edition ed. New Jersey: Prentice Hall; 2009.